Ionis Pharmaceuticals | IONS - Nettoeinkommen





Nettoeinkommen Veränderung Datum
Agios Pharmaceuticals USD -99.11M 8.93M 2026-03
Alnylam Pharmaceuticals USD 164.49M 41.5M 2026-06
Arrowhead Research USD -194.28M 61.55M 2026-06
Astellas Pharma JPY 141.83B 98.31B 2026-06
BioCryst Pharmaceuticals USD 78.4M 167.45M 2026-06
BioMarin Pharmaceutical USD 44.76M 60.76M 2026-06
Celltrion KRW 8.82B 64.74M 2026-03
Cspc Pharmaceutical CNY 370.72M 592.81M 2025-12
Deva Holding AS TRY 583.98M 319.1M 2023-09
Divis Laboratories Ltd INR 9.02B 1.51B 2026-06
Exelixis USD 212.05M 1.58M 2026-06
Halozyme Therapeutics USD 229.91M 79.86M 2026-06
Ionis Pharmaceuticals USD -114.65M 21.65M 2026-06
Kangmei Pharma CNY -16.56M 12.74M 2026-03
Knight Therapeutics CAD -3.79M 8.83M 2025-09
Laboratorios Farma EUR 103.69M 37.04M 2023-12
Malin Corporation EUR -1.1M 2.2M 2023-12
Medical Developments International AUD -226K 121K 2025-12
Moderna USD -1.34B 517M 2026-03
Nektar Therapeutics USD -44.9M 8.82M 2026-03
Neuren Pharmaceuticals AUD 15.4M 7.88M 2025-12
Neurocrine Biosciences USD 144.4M 53.5M 2026-06
Novartis USD 3.26B 108M 2026-06
Omeros USD -32.23M 23.81M 2024-09
OPKO Health USD -54.85M 23.59M 2026-03
Organigram Holdings CAD -921K 20.89M 2026-03
Ovoca Bio EUR 4.42M 5.19M 2025-12
Pfizer USD -248M 2.94B 2026-06
Pharma Mar EUR -972K 2.5M 2026-06
PTC Therapeutics USD -2.81M 132.16M 2026-03
Qiagen NV USD 103.4M 35.36M 2026-06
Regeneron Pharmaceuticals USD 1.3B 569.7M 2026-06
Roche Holding CHF 6.87B 1.4B 2026-06
Sarepta Therapeutics USD 330.96M 743.18M 2026-03
Sartorius EUR 65.9M 9.7M 2026-06
Sino Biopharmaceutical CNY 3.39B 2.91B 2025-06
Tilray USD -44.93M 44.61M 2025-09
Ultragenyx Pharmaceutical USD -185M 56M 2026-03
Vertex Pharmaceuticals USD 1.1B 68.4M 2026-06
Zealand Pharma A/S -394M 14.88M 2026-03
Zz Pientze Pharmaceu CNY 349.49M 393.99M 2026-06